DOPAMINE

Test Ligands Values Explained

Test Ligand ID - A unique identifier for the test ligand
Ligand Name - Name of the test ligand

Test Ligand ID728
Ligand NameDOPAMINE
PubMed Compound Id681
StructureProduct Image
Molecular FormulaC8H11NO2
Molecular Weight153.18
SMILESC1=CC(=C(C=C1CCN)O)O
Synonymsdopamine
4-(2-Aminoethyl)benzene-1,2-diol
51-61-6
3-Hydroxytyramine
Oxytyramine
Hydroxytyramin
Dopamin
3,4-dihydroxyphenethylamine
hydroxytyramine
4-(2-Aminoethyl)catechol
2-(3,4-dihydroxyphenyl)ethylamine
Dopamina
Dopaminum
4-(2-Aminoethyl)pyrocatechol
3,4-Dihydroxyphenylethylamine
4-(2-Aminoethyl)-1,2-benzenediol
ASL 279
Pyrocatechol, 4-(2-aminoethyl)-
1,2-Benzenediol, 4-(2-aminoethyl)-
Dopaminum [INN-Latin]
Dopamina [INN-Spanish]
Dobutamine a
A-dopamine
KW-3-060
NSC 173182
HSDB 3068
UNII-VTD58H1Z2X
EINECS 200-110-0
VTD58H1Z2X
NSC-173182
DTXSID6022420
CHEBI:18243
DTXCID602420
3,4 Dihydroxyphenethylamine
Dopaminum (INN-Latin)
Dopamina (INN-Spanish)
NORADRENALINE TARTRATE IMPURITY C (EP IMPURITY)
NORADRENALINE TARTRATE IMPURITY C [EP IMPURITY]
DOBUTAMINE HYDROCHLORIDESPECIFIED IMPURITY A (EP IMPURITY)
DOBUTAMINE HYDROCHLORIDESPECIFIED IMPURITY A [EP IMPURITY]
Dopamine1515
200-110-0
medopa
intropin
Dophamine
L-DOPAMINE
3-Hydroxtyramine
alpha-(3,4-Dihydroxyphenyl)-beta-aminoethane
4-(2-aminoethyl)-pyrocatechol
Dopamine (INN)
a-(3,4-Dihydroxyphenyl)-b-aminoethane
4-(2-Aminoethyl)-1,2-bezenediol
50444-17-2
Revimine
LDP
NCGC00015519-05
Pyrocatechol, 4-(2-aminoethyl)- (8CI)
DOPAMINE [INN]
Dopamine [INN:BAN]
.alpha.-(3,4-Dihydroxyphenyl)-.beta.-aminoethane
(3H)-Dopamine
Pyrocatechol, 4-(2-aminoethyl)-, hydrochloride
62-31-7 (HYDROCHLORIDE)
CAS-51-61-6
Medopa (TN)
NSC169105
1,2-Benzenediol, 4-(2-aminoethyl)- (9CI)
Intropin [*hydrochloride*]
4-(2-Aminoethyl)-1,2-benzenediol hydrochloride
4-(2-aminoethyl)benzene-1,2-diol;hydrochloride
SR-01000075366
.beta.-(3,4-Dihydroxyphenyl)ethylamine hydrochloride
m-Hydroxytyramine-
Dopamine (USAN)(*hydrochloride*)
IP 498
MFCD00130258
Intropin (Salt/Mix)
Spectrum_001012
1,2-Benzenediol, 4-(2-aminoethyl)-, labeled with tritium
DOPAMINE [HSDB]
DOPAMINE [MI]
CHEMBL59
DOPAMINE [VANDF]
Spectrum2_001023
Spectrum3_000406
Spectrum4_000525
Spectrum5_000945
Lopac-H-8502
Biomol-NT_000001
bmse000909
bmse000933
DOPAMINE [WHO-DD]
SCHEMBL8505
1, 4-(2-aminoethyl)-
Lopac0_000586
Oprea1_088821
BSPBio_001932
GTPL940
KBioGR_001129
KBioGR_002388
KBioGR_002484
KBioSS_001492
KBioSS_002393
KBioSS_002491
cid_65340
BIDD:ER0506
DivK1c_000780
SPECTRUM1505155
SPBio_001205
BPBio1_001123
153C5321-5FEE-4B0B-8925-F388F0EEEBD1
BDBM55121
KBio1_000780
KBio2_001492
KBio2_002388
KBio2_002484
KBio2_004060
KBio2_004956
KBio2_005052
KBio2_006628
KBio2_007524
KBio2_007620
KBio3_001152
KBio3_002867
KBio3_002962
cMAP_000036
cMAP_000065
NINDS_000780
HMS3743I03
BCP34189
Tox21_110167
2-(3, 4-Dihydroxyphenyl)ethylamine
2-(3,4-dihydroxyphenyl) ethylamine
BBL013043
STK301601
3,4-DihydroxyphenylA currencythylamin
AKOS003790978
Tox21_110167_1
CCG-204675
DB00988
FS-5341
MSK000570-100M
SDCCGSBI-0050568.P005
2-(3,4-Dihydroxyphenyl)-1-ethanamine
4-(2-Amino-ethyl)-benzene-1,2-diol
4-(2-Aminoethyl)-1,2-benzenediol #
IDI1_000780
UPCMLD0ENAT5885989:001
NCGC00015519-01
NCGC00015519-02
NCGC00015519-03
NCGC00015519-04
NCGC00015519-07
NCGC00015519-08
NCGC00015519-09
NCGC00015519-10
NCGC00015519-11
NCGC00015519-13
NCGC00015519-25
NCGC00096050-01
NCGC00096050-02
NCGC00096050-03
NCGC00096050-04
NCGC00096050-05
BP-23276
Dopamine Solution in Methanol, 100ug/mL
4-(2-aminoethyl)pyrocatechol;hydrochloride
SBI-0050568.P004
benzene, 1-(2-amino)ethyl-3,4-dihydroxy-
NS00000608
EN300-35022
C03758
D07870
F21485
4-(2-azanylethyl)benzene-1,2-diol;hydrochloride
AB00053463-12
AB00053463_13
AB00053463_14
L000232
Q170304
SR-01000075366-7
BRD-K43887077-003-25-5
BRD-K43887077-003-26-3
BRD-K43887077-003-27-1
DOBUTAMINE HYDROCHLORIDE IMPURITY A [EP IMPURITY]
Oseltamivir-d3;Hydroxytyramin;4-(2-Aminoethyl)benzene-1,2-diol
86389-83-5
Created AtJan 13, 2025 2:47 pm
Updated AtJan 13, 2025 2:47 pm